We rank companies based on fund manager, research analyst and news sentiment
AORT stock icon

Artivion
AORT

$20.21
1.35%
 

About: Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.

Employees: 1,500

0
Funds holding %
of 6,474 funds
0
Analysts bullish %
of 5 analysts
0
News positive %
of 4 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

18% more capital invested

Capital invested by funds: $515M [Q3] → $610M (+$94.3M) [Q4]

0.23% more ownership

Funds ownership: 82.82% [Q3] → 83.05% (+0.23%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

1% less funds holding

Funds holding: 140 [Q3] → 139 (-1) [Q4]

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

24% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 55

63% less call options, than puts

Call options by funds: $168K | Put options by funds: $454K

Research analyst outlook

5 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$22
9%
upside
Avg. target
$23
15%
upside
High target
$25
24%
upside

5 analyst ratings

positive
100%
neutral
0%
negative
0%
Needham
Mike Matson
24%upside
$25
Buy
Maintained
8 Apr 2024
Stifel
Rick Wise
9%upside
$22
Buy
Maintained
16 Feb 2024
Needham
Mike Matson
24%upside
$25
Buy
Maintained
16 Feb 2024
Needham
Mike Matson
9%upside
$22
Buy
Reiterated
7 Dec 2023
Needham
Mike Matson
9%upside
$22
Buy
Maintained
3 Nov 2023

Financial journalist opinion

Based on 4 articles about AORT published over the past 30 days